Akston Biosciences

Akston Biosciences is a pet biotechnology company focused on developing and commercializing innovative biopharmaceutical products for cats, dogs, and other companion animals. We believe the pet health market is in a phase of rapid growth, with increasing demand for innovative therapies that extend pets' lifespans and improve their quality of life. Our current portfolio includes several candidate products, all of which are large-molecule biologics aimed at addressing critical needs in major disease areas for pets, such as canine urothelial carcinoma (bladder cancer), canine atopic dermatitis, chronic pain associated with canine arthritis, and feline obesity and metabolic disorders.